Benjamin Hohl Insider Profile

4 Followers
Benjamin Hohl, CFO at Enliven Therapeutics, holds 0.00 shares in Enliven Therapeutics (Ticker: ELVN).
tipranks
Benjamin Hohl

Benjamin Hohl
Enliven Therapeutics (ELVN)
CFO

Not Ranked
Benjamin Hohl has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Benjamin Hohl does not currently own shares as a corporate insider.
A breakdown of Benjamin Hohl's holdings

Insider Roles

Enliven Therapeutics
(ELVN)
CFO
Roles that Benjamin Hohl holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Benjamin Hohl

Benjamin Hohl's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Enliven Therapeutics
Oct 30, 2024
CFO
Uninformative Buy
15.50K
$0.00
Benjamin Hohl has not reported any informative transactions for ELVN, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 27, 2023
Uninformative Buy
$2.80K
-
$2.48
Jan 02, 2024
Uninformative Buy
$29.44K
-
$2.48
Jan 31, 2024
Uninformative Buy
$8.06K
-
$2.48
Feb 29, 2024
Uninformative Buy
$8.06K
-
$2.48
Mar 29, 2024
Uninformative Buy
$8.06K
-
$2.48
List of latest transactions for each holding click on a transaction to see Benjamin Hohl's performance on stock

Benjamin Hohl insider profile FAQ

What is the percentage of profitable transactions made by Benjamin Hohl?
The percentage of profitable transactions made by Benjamin Hohl is ―.
    What is the average return per transaction made by Benjamin Hohl?
    The average return per transaction made by Benjamin Hohl is ―.
      What stocks does Benjamin Hohl hold?
      Benjamin Hohl holds: ELVN stocks.
        What was Benjamin Hohl’s latest transaction?
        Benjamin Hohl latest transaction was an Uninformative Buy of $15.50K.
          What was Benjamin Hohl's most profitable transaction?
          Benjamin Hohl’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Benjamin Hohl's role in Enliven Therapeutics?
            Benjamin Hohl's role in Enliven Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.